Rubicon Research Limited (NSE:RUBICON)
India · Delayed Price · Currency is INR 1,798.70
+179.60 (11.09%)
At close: Aug 17, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 297.74 billion as of August 17, 2026.
Market Cap
297.74B
Enterprise Value
297.52B
Revenue
17.54B
Ranking
n/a
PE Ratio
117.49
Stock Price
1,798.70
ChartMarket Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 297.74B, an increase of 187.68%. That is a compound annual growth rate of 254.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 297.74B | 165.48% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 575.37B |
| GlaxoSmithKline Pharmaceuticals | 455.55B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 212.63B |
| AstraZeneca Pharma India | 193.84B |
| Caplin Point Laboratories | 188.55B |
| Jubilant Pharmova | 136.92B |
| CORONA Remedies | 130.71B |